Europe’s Innovation Gap Is a Handover Problem
Europe’s innovation gap is increasingly found between instruments, not inside them.
The continent has world-class research, ambitious funding programmes, corporate innovation teams, investors and public procurement. Each part can perform well on its own. Yet promising technologies still lose momentum on the way from laboratory to venture, pilot to procurement and financing to industrial deployment.
The missing capability is often the handover.
Every instrument optimises its own mandate
Research funding rewards scientific quality and project delivery. Technology transfer offices protect IP and negotiate rights. Accelerators prepare ventures for investors. Funds evaluate ownership and returns. Procurement manages operational risk.
These mandates are legitimate, but they use different evidence, timelines and definitions of success. A result that satisfies one institution may be unusable for the next. A pilot proves interest but not purchasing authority. A patent supports defensibility but not manufacturing readiness. A grant milestone shows progress but not market adoption.
When nobody owns the space between mandates, technologies fall into an accountability gap.
Information is lost at every transition
Handovers frequently reduce complex evidence to a deck, score or committee summary. Technical assumptions, negative results and unresolved dependencies disappear. The next actor repeats market research or technology assessment because the earlier work was not structured for reuse.
This weakens stakeholder management and slows commercialization. Teams must rebuild trust, reinterpret the asset and discover risks that were already visible upstream. Funding continues, but institutional learning does not compound.
The gap is especially damaging in deep tech, where technology, IP, regulation, capital and industrial integration are tightly coupled. A missed dependency can invalidate progress across several workstreams.
Design handovers as decision infrastructure
A strong handover begins before the transition. The receiving decision-maker should define what evidence will be needed, in what form and by which date. The current owner should record assumptions, thresholds, open risks and the decision history.
Shared evidence architecture creates continuity without forcing every institution into the same process. It clarifies who owns the next decision, what would justify commitment and what signal should trigger a stop or redesign.
Independent innovation assessment can bridge the interfaces where incentives differ. Arise Innovations® reviews decisions across technology, market, IP, regulation, capital, team and execution, creating a written basis that can travel between institutions and remain open to scrutiny.
Europe does not lack instruments. It lacks reliable conversion between them. More programmes will not solve a problem created by weak interfaces.
Innovation scales when responsibility crosses the boundary with the asset.
Want the full analysis? Read the complete essay for the broader systems argument on finance, control, procurement and measurement—and why Europe’s next advantage may depend on owning the space between them.
Kommentare